LoginSignup
BICO Group logo

BICO Group

Stock
Stock
ISIN: SE0013647385
Ticker: BICO
SE0013647385
BICO

Price

Price

CHART BY

Frequently asked questions

The market capitalization of BICO Group is $148.84M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BICO Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.226. EPS indicates the company's profitability on a per-share basis.
Currently, 3 analysts cover BICO Group's stock, with a consensus target price of $2.613. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, BICO Group reported a revenue of $155.13M.
BICO Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $6.16M. EBITDA measures the company's overall financial performance.
BICO Group has a free cash flow of -$206.26K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
The free float of BICO Group is 48.22M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$148.84M
EPS (TTM) 
-$1.226
Free Float 
48.22M
Revenue (TTM) 
$155.13M
EBITDA (TTM) 
$6.16M
Free Cashflow (TTM) 
-$206.26K

Pricing

1D span
$2.106$2.178
52W span
$1.339$2.652

Analyst Ratings

The price target is $2.613 and the stock is covered by 3 analysts.

Buy

1

Hold

2

Sell

0

Information

BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. It operates through the following segments: Bioprinting, Life Science Solutions, Lab Automation, and Group. The Bioprinting segment includes 3D bioprinters and bioinks with a wide range of technologies for different demanding applications, resolutions, and volume and speed requirements, as well as services focused on accelerating drug discovery and development with advanced tissue imaging and cell culture services. The Life Science Solutions segment supplies advanced lab instrumentation and smart workflow connectivity software to analyze data from applications in cell culture, cell imaging, cell sorting, and sample preparation for different analytics such as genomics. The Lab Automation segment offers proprietary and hardware-agnostic Green Button Go Suite software for connected and smart workflows. The Group segment is involved in the group’s administration and shareholder costs. The company was founded by Erik Paul Gatenholm and Hector Daniel Martinez Avila in March 2015 and is headquartered in Gothenburg, Sweden.

Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
SE0013647385
Primary Ticker
BICO

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin